drugset / Trial / NCT02202395
Hydroxytriptolide in Active Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to investigate the efficacy and safety of Hydroxytriptolide(LTS) in active rheumatoid arthritis patients with an inadequate response to methotrexate.
Timeline
- Start
- 2014-06
- Primary completion
- 2015-04-30
- Completion
- 2016-12-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | LTS | Unknown | 0.25 mg | — |
| Comparator | LTS | Unknown | 0.5 mg | — |
| Comparator | LTS | Unknown | 1 mg | — |